Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70376 - 70400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ELOA	6924	upregulated	Silicon Dioxide analog results in increased expression of ELOA mRNA	1p36.11	A24195
Silicon dioxide	Approved	ELOB	6923	upregulated	Silicon Dioxide results in increased expression of ELOB mRNA	16p13.3	A24196
Silicon dioxide	Approved	ELOVL3	83401	downregulated	Silicon Dioxide analog results in decreased expression of ELOVL3 mRNA	10q24.32	A24195
Silicon dioxide	Approved	ELOVL4	6785	upregulated	Silicon Dioxide analog results in increased expression of ELOVL4 mRNA	6q14.1	A24194 A24195
Silicon dioxide	Approved	ELOVL4	6785	upregulated	Silicon Dioxide results in increased expression of ELOVL4 mRNA	6q14.1	A24196
Silicon dioxide	Approved	ELOVL7	79993	upregulated	Silicon Dioxide analog results in increased expression of ELOVL7 mRNA	5q12.1	A24194
Silicon dioxide	Approved	EMD	2010	downregulated	Silicon Dioxide analog results in decreased expression of EMD mRNA	Xq28	A24195
Silicon dioxide	Approved	EME2	197342	upregulated	Silicon Dioxide analog results in increased expression of EME2 mRNA	16p13.3	A24195
Silicon dioxide	Approved	EMG1	10436	upregulated	Silicon Dioxide analog results in increased expression of EMG1 mRNA	12p13.31	A24195
Silicon dioxide	Approved	EMID1	129080	downregulated	Silicon Dioxide analog results in decreased expression of EMID1 mRNA	22q12.2	A24195
Silicon dioxide	Approved	EML2	24139	downregulated	Silicon Dioxide analog results in decreased expression of EML2 mRNA	19q13.32	A24195
Silicon dioxide	Approved	EML4	27436	downregulated	Silicon Dioxide analog results in decreased expression of EML4 mRNA	2p21	A24195
Silicon dioxide	Approved	EMP1	2012	upregulated	Silicon Dioxide analog results in increased expression of EMP1 mRNA	12p13.1	A24195
Silicon dioxide	Approved	EMP1	2012	upregulated	Silicon Dioxide results in increased expression of EMP1 mRNA	12p13.1	A24196
Silicon dioxide	Approved	EMP2	2013	downregulated	Silicon Dioxide analog results in decreased expression of EMP2 mRNA	16p13.13	A24195
Silicon dioxide	Approved	EMP3	2014	upregulated	Silicon Dioxide analog results in increased expression of EMP3 mRNA	19q13.33	A24195
Silicon dioxide	Approved	EMX2	2018	downregulated	Silicon Dioxide analog results in decreased expression of EMX2 mRNA	10q26.11	A24194
Silicon dioxide	Approved	EN2	2020	downregulated	Silicon Dioxide analog results in decreased expression of EN2 mRNA	7q36.3	A24195
Silicon dioxide	Approved	ENC1	8507	upregulated	Silicon Dioxide analog results in increased expression of ENC1 mRNA	5q13.3	A24195
Silicon dioxide	Approved	ENC1	8507	upregulated	Silicon Dioxide results in increased expression of ENC1 mRNA	5q13.3	A24196
Silicon dioxide	Approved	ENDOU	8909	upregulated	Silicon Dioxide analog results in increased expression of ENDOU mRNA	12q13.11	A24194
Silicon dioxide	Approved	ENDOV	284131	downregulated	Silicon Dioxide analog results in decreased expression of ENDOV mRNA	17q25.3	A24195
Silicon dioxide	Approved	ENO2	2026	upregulated	Silicon Dioxide analog results in increased expression of ENO2 mRNA	12p13.31	A24195
Silicon dioxide	Approved	ENO2	2026	upregulated	Silicon Dioxide results in increased expression of ENO2 mRNA	12p13.31	A24196
Silicon dioxide	Approved	ENOSF1	55556	downregulated	Silicon Dioxide results in decreased expression of ENOSF1 mRNA	18p11.32	A24196

Displaying entries 70376 - 70400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability